摘要
Atopic dermatitis (AD) is a common inflammatory disease and it is very difficult to treat. In the present work, a series of costunolide derivatives have been prepared, and in vitro and in vivo anti-inflammatory activities have evaluated. The results showed that most derivatives displayed good inhibition of NO generation with low cytotoxicity, and 7d could inhibit the phosphorylation of P38, P65 NF-xB and IxB-alpha in LPS-induced RAW264.7 model. The in vivo researches showed that 7d could improve skin injury symptoms, decrease Th2-type cytokine levels, inhibit HIS levels, alleviate scratching and repaire the damaged skin barrier through the inhibition of phosphorylation of MAPK and NF-xB signaling pathways on MC903-induced AD model. Therefore, costunolide derivatives may be new potent anti-AD agents for further study.
学科与关键词
- Jianpi Yangxue Qufeng compound alleviates atopic dermatitis via TLR4/MyD88/NF-κB signaling pathwayYang, Xuesong; Wang, Zhimin; Huang, Hong; Luo, Guangyun; Cong, Lin; Yang, Jianting; Ye, Jianzhou*Heliyon, 2024, 10(1): e23278.
- Cimifugin Mechanism of Action from Saposhnikovia divaricata in the Treatment of Atopic DermatitisChen, Meng-Meng; Du, Wen-Xia; Dong, Chen-Qing; Gao, Jie; Mu, De-Song; Ma, Fang-Qi; Li, Xue-Huan; Li, Xing-Yi; Qu, Lu*Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy, 2024.
- Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivoWu, Qing; Mo, Xiumei; Lin, Ying; Liu, Junfeng; Ye, Siqi; Zhang, Yu; Fan, Xingxing; Chen, Dacan*; Yan, Fenggen*Annals of Translational Medicine, 2022, 10(18).被引 1
